Angola Registers the Sputnik Light Vaccine

The Food and Drug Authority (FDA) of the Republic of Angola confirmed on May 12, 2021, the registration of the single-component Sputnik Light vaccine. The FDA granted Sputnik V an emergency use authorization.

The Russian Direct Investment Fund (RDIF) stated in a press release 'the Sputnik Light vaccine is the first component (recombinant human adenovirus 26 serotype (rAd26)) of the Sputnik V vaccine, which was authorized in Angola in March 2021. The RDIF says the effectiveness of the single-component vaccine "Sputnik Light" is 79.4% from the 28th day after vaccination.

On May 6, 2021, the Ministry of Health of the Russian Federation, the National Research Center for Epidemiology and Microbiology, and the RDIF announced the registration of the Sputnik Light vaccine.

Angola is a Southern African nation of about 31 million residents that primarily speaks Portuguese. With tropical Atlantic beaches to the west, located near the Sub-Saharan desert, Angola is administratively divided into 18 provinces and 163 municipalities.

In Angola, the US Embassy says most COVID-19 cases are in the capital city of Luanda, but COVID-19 has been confirmed throughout the provinces.  Please visit the Angolan COVID-19 Commission’s website for the most up-to-date case numbers.